Peiyuan Lv Selected Research

Ligation

9/2015

Lipoxin A4 methyl ester alleviates vascular cognition impairment by regulating the expression of proteins related to autophagy and ER stress in the rat hippocampus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peiyuan Lv Research Topics

Disease

14	Vascular Dementia (Subcortical Arteriosclerotic Encephalopathy) 05/2022 - 07/2013
13	Cognitive Dysfunction 05/2022 - 09/2014
6	Brain Ischemia (Cerebral Ischemia) 10/2022 - 02/2014
4	Stroke (Strokes) 01/2022 - 07/2013
3	Reperfusion Injury 10/2022 - 02/2014
3	Inflammation (Inflammations) 10/2022 - 09/2015
3	Ischemia 10/2022 - 04/2021
3	Ischemic Stroke 01/2022 - 07/2013
3	Epilepsy (Aura) 01/2020 - 05/2013
2	Neuroinflammatory Diseases 05/2022 - 01/2022
2	Memory Disorders (Memory Loss) 01/2022 - 10/2017
2	Cerebral Infarction 04/2021 - 01/2018
1	Hypoxia (Hypoxemia) 10/2022
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2022
1	Alzheimer Disease (Alzheimer's Disease) 04/2021
1	Mitochondrial Diseases (Mitochondrial Disease) 04/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Cerebral Small Vessel Diseases 01/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2020
1	Brain Injuries (Brain Injury) 11/2020
1	Infarction (Infarctions) 01/2017
1	Dementia (Dementias) 02/2016
1	Seizures (Absence Seizure) 05/2013

Drug/Important Bio-Agent (IBA)

8	Neuroprotective AgentsIBA 09/2021 - 07/2013
7	3-n-butylphthalide (butylphthalide)IBA 01/2022 - 07/2013
3	Pharmaceutical PreparationsIBA 01/2022 - 07/2013
2	AntioxidantsIBA 10/2022 - 01/2022
2	EdaravoneIBA 10/2022 - 01/2018
2	IronIBA 01/2022 - 11/2019
2	CateninsIBA 09/2021 - 09/2020
2	Estrogens (Estrogen)FDA Link 09/2021 - 09/2020
2	Proteins (Proteins, Gene)FDA Link 04/2021 - 10/2017
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 01/2021 - 09/2015
2	Lithium ChlorideIBA 11/2020 - 09/2015
2	HydrogenIBA 11/2019 - 01/2019
2	Therapeutic UsesIBA 01/2019 - 07/2013
2	Phosphotransferases (Kinase)IBA 10/2017 - 07/2013
2	lipoxin A4IBA 09/2015 - 09/2014
1	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2022
1	Cysteine (L-Cysteine)FDA Link 05/2022
1	Aspartic Acid (Aspartate)FDA Link 05/2022
1	InterleukinsIBA 05/2022
1	NucleotidesIBA 05/2022
1	Peptide Hydrolases (Proteases)FDA Link 05/2022
1	Peptide Initiation Factors (Initiation Factor)IBA 05/2022
1	SmokeIBA 05/2022
1	Caspase 1 (ICE Protease)IBA 05/2022
1	Liposomes (Liposome)IBA 01/2022
1	Sirtuin 3IBA 01/2022
1	Sirolimus (Rapamycin)FDA Link 04/2021
1	HomocysteineIBA 01/2021
1	shikoninIBA 01/2021
1	Metformin (Glucophage)FDA LinkGeneric 01/2021
1	LithiumIBA 11/2020
1	Sirtuin 1IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	oxiracetamIBA 01/2019
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 10/2017
1	Nimodipine (Modus)FDA LinkGeneric 01/2017
1	lipoxin A4 methyl esterIBA 09/2015
1	CalpainIBA 02/2014
1	CyclinsIBA 02/2014
1	Donepezil (Aricept)FDA LinkGeneric 02/2014
1	thionineIBA 07/2013
1	Neuropeptide YIBA 05/2013
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 05/2013
1	Kainic Acid (Kainate)IBA 05/2013

Therapy/Procedure

1	Lasers (Laser) 04/2021
1	Therapeutics 01/2018
1	Secondary Prevention 01/2018
1	Thrombectomy 01/2017
1	Ligation 09/2015